Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Titel:
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Auteur:
Cho, Hyungwoo Ryu, Min-Hee Kim, Kyu-pyo Ryoo, Baek-Yeol Park, Sook Ryun Kim, Bum Soo Lee, In-Seob Kim, Hee-Sung Yoo, Moon-Won Yook, Jeong Hwan Oh, Seong Tae Kim, Byung Sik Kang, Yoon-Koo